Australia's largest stock trading and investment forum Australia's #1 stock forum

CPH

Click for more information

0.00%

0.9¢ creso pharma limited

Ann: Halucenex Update, page-5

First 5 Last

Share
Profile

Follow
surfthemarket

464 Posts.

222

09/02/22

10:17

Post #: 59449658
Share

Originally posted by edwardc: ↑

Creso Pharma Limited (ASX:CPH, OTC:COPHF, FRA:1X8) (‘Creso Pharma’ or ‘the Company’) is
pleased to advise that its wholly-owned, Canadian based psychedelics subsidiary, Halucenex Life
Sciences Inc. (“Halucenex”) has been included on a list of companies that can provide psychedelic
compounds to researchers and patients under the SAP. The SAP is a federal program that allows
healthcare professionals to apply for access to non-marketed medications that have not yet been
approved for sale when such medications show clinical evidence of safety and efficacy and are
intended to treat patients with severe or life-threatening illnessii.

it will take years before clinical evidence help push legislation changes and commercializing this into a profitable revenue stream.... until that happens.. the cash burn is not sustainable and imagine the amount of capital raises needed to keep this afloat to reach that goal...

but I guess as long as you the holder is happy.. that's most important. =)

Expand

.......... but your fellow basher - tradingguy - says not enough is being spent on R&D ??? I'm confused.

CPH Price at posting: 8.8¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 12 more messages in this thread...

First 5 Last

Add CPH (ASX) to my watchlist